Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

437
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
437
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.4K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.4K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

10.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
10.7K
Allosteric Regulation01:08

Allosteric Regulation

57.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

12.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical toxicological evaluation of 7-methoxy-3-Phenyl-4H-Chromen-4-one: Acute and sub-acute oral toxicity with histopathological correlation.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

Identification of novel pyrazole-containing thiazolidine-2,4-dione derivatives as potent α-glucosidase inhibitors: design, synthesis and antidiabetic assessment.

Bioorganic chemistry·2026
Same author

Heterocyclic GABAA Receptor Modulators: Emerging Therapeutic Strategies for Epilepsy Management.

Chemistry & biodiversity·2026
Same author

From exposure to injury: signaling mechanisms of microplastic-induced renal toxicity: an extensive review.

Toxicology mechanisms and methods·2026
Same author

Five-year Outcomes From a Career Exploration Pilot Program for Developmental & Behavioral Pediatrics.

Journal of developmental and behavioral pediatrics : JDBP·2026
Same author

Improving Health-Related Social Needs Screening and Support Across a Pediatric Health Care System.

Pediatrics·2026

Related Experiment Video

Updated: May 11, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.4K

Pyrazole and Pyrazoline-Based EGFR TK Inhibitors: A Review Study Emphasizing Structure-Activity Relationship (SAR).

Shruti Mittal1, Ozair Alam1, Lakshay Singh1

  • 1Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi-110062, India.

Medicinal Chemistry (Shariqah (United Arab Emirates))
|April 18, 2025
PubMed
Summary

This review explores pyrazole and pyrazoline derivatives as potential anti-cancer agents targeting EGFR mutations. It emphasizes structure-activity relationships to optimize these compounds for inhibiting tumor growth and overcoming drug resistance.

Keywords:
CancerEGFRPyrazolePyrazolineSARTyrosine kinase inhibitors.

More Related Videos

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K

Related Experiment Videos

Last Updated: May 11, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.4K
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.2K

Area of Science:

  • Oncology
  • Medicinal Chemistry

Background:

  • Epidermal Growth Factor Receptor (EGFR) abnormalities drive uncontrolled cell growth and carcinoma development.
  • Cancer cells develop resistance to treatments like tyrosine kinase inhibitors (TKIs) due to EGFR-associated gene mutations.
  • Fourth-generation TKIs targeting the C797S mutation are current standards for EGFR-mutated cancers.

Purpose of the Study:

  • To review pyrazole and pyrazoline derivatives as potential anti-cancer agents.
  • To analyze structure-activity relationships (SAR) of these compounds against EGFR tyrosine kinase inhibitors.
  • To guide optimization of novel antiproliferative agents.

Main Methods:

  • Literature review of anti-cancer agents developed over the last 15 years.
  • Focus on pyrazole and pyrazoline derivatives.
  • Analysis of compound activity and SAR.

Main Results:

  • Identified 31 potential anti-cancer compounds.
  • Detailed activity characteristics and SAR for pyrazole and pyrazoline derivatives.
  • Highlighted compounds as EGFR tyrosine kinase inhibitors.

Conclusions:

  • Pyrazole and pyrazoline scaffolds show promise as EGFR inhibitors.
  • SAR analysis is crucial for optimizing antiproliferative efficacy.
  • Further research can lead to improved cancer therapies overcoming resistance.